Further insight into the precise mechanisms of CCR2/CCL2 in ALI and identification of disease settings in which modification of this axis might be of avail are required to benefit from the recent advances in the development of therapeutic strategies. This evidence concerns the gene CCR2 and acute respiratory distress syndrome.